Ignite Creation Date:
2024-05-06 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03601611
Status:
COMPLETED
Last Update Posted:
2020-04-21
First Post:
2018-07-01
Brief Title:
Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms
Sponsor:
Herlev Hospital
Organization:
Herlev Hospital
Organization Data
Organization:
Herlev Hospital
Class:
OTHER
Study ID:
AA 1820
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Herlev Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Inna Chen MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Herlev Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |